Microbial Strain Engineering for Glutathione Production Efficiency
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing glutathione and associated compounds like γ-glutamylcysteine, bis-γ-glutamylcystine, γ-glutamylcystine, reduced glutathione, and oxidized glutathione through microbial fermentation face challenges due to low productivity and the need for expensive substrates, as well as poor practicality.
Innovation Solution
A microbial strain with enhanced expression of serine-O-acetyltransferase and specific gene modifications, including disruption of γ-glutamyltransferase and enhanced expression of glutamate-cysteine ligase and glutathione synthetase, is used for efficient production of these compounds, reducing the reliance on external substrates and improving yield.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional fermentation methods are used for glutathione production, then production can be achieved, but productivity is low and expensive substrates are required
Solution Approach 1:
The patent changes the biochemical parameters of the E. coli strain by enhancing the expression of serine-O-acetyltransferase and modifying other relevant genes. This enables the bacteria to produce glutathione more efficiently using cheaper substrates, transforming the metabolic parameters to resolve the contradiction between productivity and substrate cost
Solution Approach 2:
The modified E. coli strain is engineered to serve itself by producing the necessary enzymes and metabolic intermediates for glutathione synthesis endogenously. The enhanced serine-O-acetyltransferase expression enables the strain to generate O-acetyl-L-serine internally, reducing dependence on expensive external substrates while maintaining high productivity
2Quantity of substance
If E. coli strains overexpressing gshA and gshB genes are cultured, then glutathione can be produced in the medium, but the concentration remains low at 160 mg/l
Solution Approach 1:
The patent combines multiple gene modifications in a single E. coli strain: enhancement of serine-O-acetyltransferase expression, disruption of γ-glutamyltransferase, and enhancement of glutamate-cysteine ligase and glutathione synthetase. This merging of modifications creates a synergistic effect that simultaneously increases glutathione concentration and production efficiency
Solution Approach 2:
The patent performs preliminary metabolic preparation by enhancing serine-O-acetyltransferase expression to increase the pool of O-acetyl-L-serine before glutathione synthesis. This preliminary accumulation of precursor molecules enables more efficient downstream conversion to glutathione, increasing both concentration and productivity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The approach results in a significant increase in the production efficiency of the target compounds, enhancing the practicality and cost-effectiveness of glutathione production by microbial fermentation.
Implementation Method 1
a method for producing glutathione or γ-glutamylcysteine comprising culturing microorganisms with activity of proteins having glutathione transport activity and activity of proteins involved in biosynthesis of glutathione or γ-glutamylcysteine higher than those of parent strains in a medium to produce and accumulate glutathione or γ-glutamylcysteine in the medium
Data Source
AI summary
This invention is intended to improve glutathione productivity by fermentation using microorganisms. This invention relates to a microbial strain capable of overexpression of γ-glutamylcysteine, bis-γ-glutamylcystine, γ-glutamylcystine, reduced glutathione, and/or oxidized glutathione in which the expression level of a gene encoding serine-O-acetyltransferase (EC:2.3.1.30) is enhanced and a method involving the use of such microbial strain.